Disclosure Of Entity's Operating Segments [Text Block]

Xbrane Biopharma - Filing #702448

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Profit (loss) before tax
183 226 SEK
218 126 SEK
Profit (loss) from continuing operations
183 226 SEK
218 126 SEK
Profit (loss)
188 376 SEK
188 376 SEK
226 026 SEK
226 026 SEK
Assets
688 427 SEK
463 763 SEK
Liabilities
256 686 SEK
206 055 SEK
Cash flows from (used in) operating activities
219 610 SEK
238 407 SEK
Cash flows from (used in) investing activities
77 350 SEK
3 855 SEK
Cash flows from (used in) financing activities
349 365 SEK
322 724 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.